1044

GTD Indications Diagnosis Carrier / Cascade Testing Prenatal GTD Samples Accepted Blood DNA Cultured Cells Amniocyte CVS GTD Test Methodology CNV Sequencing GTD Methodology Notes Oligonucleotide based target capture, sanger sequencing for any clinically significant regions that are not captured and/or have insufficient coverage. Generic Test name (cms title) Cardiomyopathy GTD Test type Gene Panel GTD Location Children's Hospital of Eastern Ontario GTD Gene/Platform/Region List ABCC9, ACADVL, ACTC1, ACTN2, ALPK3, BAG3, BRAF, CACNA1C, CAV3, CSRP3, CTNNA3, DES, DMD, DSC2, DSG2, DSP, DYSF, EMD, FHL1, FHOD3, FKRP, FKTN, FLNC, GAA, GATA4, GLA, HCN4, HRAS, JPH2, JUP, KLHL24, KRAS, LAMP2, LDB3, LMNA, LZTR1, MAP2K1, MAP2K2, MIB1, MRAS, MT-TI, MYBPC3, MYH7, MYL2, MYL3, MYO6, NEXN, NKX2-5, NRAP, NRAS, OBSCN, PKP2, PLEKHM2, PLN, PPP1CB, PRDM16, PRKAG2, PTPN11, RAF1, RBM20, RIT1, RRAGD, RRAS2, RYR2, SCN5A, SHOC2, SOS1, SOS2, TAFAZZIN, TBX5, TMEM43, TMEM70, TNNC1, TNNI3, TNNI3K, TNNT2, TPM1, TRIM63, TTN, TTR, VCL GTD Category Cardiogenetics GTD Disease/Condition Cardiomyopathy